Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Majed Al Jeraisy"'
Autor:
Raghad R. Alzahrani, Manal M. Alkhulaifi, Majed Al Jeraisy, Abdulkareem M. Albekairy, Rizwan Ali, Bahauddeen M. Alrfaei, Salleh N. Ehaideb, Ahmed I. Al-Asmari, Sultan Al Qahtani, Abdulaziz Halwani, Alaa Eldeen B. Yassin, Majed A. Halwani
Publikováno v:
Pharmaceutics, Vol 16, Iss 10, p 1330 (2024)
Background and Purpose. Gentamicin (GEN) is a broad-spectrum antibiotic that cannot be prescribed freely because of its toxicity. Thymoquinone (THQ), a phytochemical, has antibacterial, antioxidant, and toxicity-reducing properties. However, its hydr
Externí odkaz:
https://doaj.org/article/e833cef17b8e4223af66162a47425604
Autor:
Hisham S. Abou-Auda, Fatimah Alotaibi, Sary Alsanea, Abdulrahman Alwhaibi, Mohammed M. Almutairi, Ziyad Alrabiah, Abdullah Alsultan, Majed Al Jeraisy
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 5, Pp 102060- (2024)
Understanding the pharmacokinetics of gentamicin is essential in special populations, such as pediatric patients with acute lymphoblastic leukemia (ALL), in light of previous studies indicating that ALL patients have a lower volume of distribution th
Externí odkaz:
https://doaj.org/article/990726c480da470ea9657ed7812e2c82
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Although patients frequently use patient information leaflets (PILs) to obtain information about medicine, their confidence in using it may be diminished after reading it. This study aimed to assess the public perception of PIL's
Externí odkaz:
https://doaj.org/article/9b5f930511d34eceab78d0e4a0000adb
Autor:
Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri, Mashan L. Abdullah, Haya A. Aljami, Hanan H. Balkhy, Majed Al Jeraisy, Yasser Mandourah, Sameera AlJohani, Shmeylan Al Harbi, Hani A. Aziz Jokhdar, Ahmad M. Deeb, Ziad A. Memish, Jesna Jose, Sameeh Ghazal, Sarah Al Faraj, Ghaleb A. Al Mekhlafi, Nisreen Murad Sherbeeni, Fatehi Elnour Elzein, Frederick G. Hayden, Robert A. Fowler, Badriah M. AlMutairi, Abdulaziz Al-Dawood, Naif Khalaf Alharbi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Animal and human data indicate variable effects of interferons in treating coronavirus infections according to inflammatory status and timing of therapy. In this sub-study of the MIRACLE trial (MERS-CoV Infection Treated with a Combination o
Externí odkaz:
https://doaj.org/article/e5a94615be554d5c80e9bfc21370cdd0
Autor:
Abdullah Alsultan, Manea Fares Al Munjem, Khulood Mohammed Atiq, Zekra Kamel Aljehani, Hessa Al Muqati, Abdullah Almohaizeie, Dalia Ahmed Ballal, Tahani Makki Refaei, Majed Al Jeraisy, Abdulmohsen Assiri, Manal Abouelkheir
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
IntroductionVancomycin dosing in very low birth weight (VLBW) neonates is challenging. Compared with the general neonatal population, VLBW neonates are less likely to achieve the vancomycin therapeutic targets. Current dosing recommendations are base
Externí odkaz:
https://doaj.org/article/499d5a50d38648aebcd1cf3d8d9e302a
Autor:
Nora Bin Yousef, Nagarajkumar Yenugadhati, Nasser Alqahtani, Ali Alshahrani, Mubarak Alshahrani, Majed Al Jeraisy, Motasim Badri
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 1, Pp 8-13 (2022)
Background: Pharmacovigilance enhances post-market drug safety. However, analytical reports of a pattern of adverse drug reactions (ADRs) experienced by patients in Saudi Arabia are demanded. Objective: To describe patterns of ADRs submitted to the S
Externí odkaz:
https://doaj.org/article/1532fdc926d041e2896aecbe0ce26cf5
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Maram Al Dossari, Asma Alshahrani, Aisha Alharbi, Rahmah Algarni, Majed Al Jeraisy, Shmeylan Al Harbi, Abdulmalik Al Katheri, Fahad Al Eidan, Abdulkareem M. Al Bekairy, Nouf Al Qahtani, Mashael Al Muqrin, Ramesh Vishwakarma, Ghassan Al Ghamdi
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-8 (2021)
Abstract Background Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critica
Externí odkaz:
https://doaj.org/article/7f86b94314f44408a3ae78015f061312
Autor:
Majed Al Jeraisy, Maissa AlFuraih, Raghad AlSaif, Bushra AlKhalifah, Hazza AlOtaibi, Mostafa A. Abolfotouh
Publikováno v:
BMC Pediatrics, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Drooling is common in children with neurological disorders, but its management is very challenging, Scopolamine transdermal patch (STP) appears to be useful in controlling drooling, although it is not approved for this indication
Externí odkaz:
https://doaj.org/article/e9d2f164f8044357b5e1ba14f44aa597
Autor:
Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri, Hani A. Aziz Jokhdar, Adel Alothman, Hanan H. Balkhy, Sameera AlJohani, Shmeylan Al Harbi, Suleiman Kojan, Majed Al Jeraisy, Ahmad M. Deeb, Ziad A. Memish, Sameeh Ghazal, Sarah Al Faraj, Fahad Al-Hameed, Asim AlSaedi, Yasser Mandourah, Ghaleb A. Al Mekhlafi, Nisreen Murad Sherbeeni, Fatehi Elnour Elzein, Abdullah Almotairi, Ali Al Bshabshe, Ayman Kharaba, Jesna Jose, Abdulrahman Al Harthy, Mohammed Al Sulaiman, Ahmed Mady, Robert A. Fowler, Frederick G. Hayden, Abdulaziz Al-Dawood, Mohamed Abdelzaher, Wail Bajhmom, Mohamed A. Hussein, and the Saudi Critical Care Trials group
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-8 (2020)
Abstract The MIRACLE trial (MERS-CoV Infection tReated with A Combination of Lopinavir/ritonavir and intErferon-β1b) investigates the efficacy of a combination therapy of lopinavir/ritonavir and recombinant interferon-β1b provided with standard sup
Externí odkaz:
https://doaj.org/article/98b352d6164e45ae9eb5230477b9fe36
Autor:
Yaseen M. Arabi, Adel Alothman, Hanan H. Balkhy, Abdulaziz Al-Dawood, Sameera AlJohani, Shmeylan Al Harbi, Suleiman Kojan, Majed Al Jeraisy, Ahmad M. Deeb, Abdullah M. Assiri, Fahad Al-Hameed, Asim AlSaedi, Yasser Mandourah, Ghaleb A. Almekhlafi, Nisreen Murad Sherbeeni, Fatehi Elnour Elzein, Javed Memon, Yusri Taha, Abdullah Almotairi, Khalid A. Maghrabi, Ismael Qushmaq, Ali Al Bshabshe, Ayman Kharaba, Sarah Shalhoub, Jesna Jose, Robert A. Fowler, Frederick G. Hayden, Mohamed A. Hussein, And the MIRACLE trial group
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-13 (2018)
Abstract Background It had been more than 5 years since the first case of Middle East Respiratory Syndrome coronavirus infection (MERS-CoV) was recorded, but no specific treatment has been investigated in randomized clinical trials. Results from in v
Externí odkaz:
https://doaj.org/article/e2349ce186d145d0a4893a860406c946